The schedule of trial enrolment, interventions and assessments
Prescreen | Baseline (t0) | Allocation | 3 weeks intervention | At immediately postintervention (t1) | 1 month after intervention (t2) | |
Informed consent | ||||||
Review study eligibility | × | |||||
Informed consent | × | |||||
Study procedures | ||||||
Randomisation | × | |||||
Demographics | × | |||||
Clinical and oncologic history | × | |||||
Intervention administration | ||||||
ACT or UC | × | |||||
Efficacy evaluation | ||||||
Body Image Scale | × | × | × | |||
IMAGE‐HN | × | × | × | |||
AAQ-II | × | × | × | |||
SCSQ | × | × | × | |||
DT | × | × | × | |||
Other evaluations | ||||||
Intervention fidelity | × | |||||
Patient adherence | × |
AAQ-II, The Acceptance and Action Questionnaire Second Edition; ACT, acceptance commitment therapy; DT, Distress Thermometer; IMAGE-HN, The Inventory to Measure and Assess imaGe disturbance-Head and Neck; SCSQ, Simplified Coping Style Questionnaire; UC, usual care.